Coebergh van den Braak, R. R. J.
ten Hoorn, S.
Sieuwerts, A. M.
Tuynman, J. B.
Smid, M.
Wilting, S. M.
Martens, J. W. M.
Punt, C. J. A.
Foekens, J. A.
Medema, J. P.
IJzermans, J. N. M.
Vermeulen, L. http://orcid.org/0000-0002-6066-789X
Funding for this research was provided by:
New York Stem Cell Foundation (NYSCF-I-R43)
KWF Kankerbestrijding ((UVA2014-7245 and UVA2013-6331)
Worldwide Cancer Research (14-1164)
Maag Lever Darm Stichting (MLDS-CDG 14-03)
H2020 European Research Council (ERG-StG 638193)
ZonMw (Vidi 016.156.308)
Fonds NutsOhra (0903-011)
Article History
Received: 13 March 2020
Accepted: 18 August 2020
First Online: 4 September 2020
Ethics approval and consent to participate
: For the MATCH Cohort ethics approval was obtained from the institutional research ethics review board of the Erasmus MC University Medical Center (number MEC-2007-088). All patients gave written informed consent for the storage and use of tissue samples for research purposes, and the collection of clinical data. For the AMC-AJCCII-90 Cohort the ethics approval was obtained and the need for consent was waived by the institutional research ethics review board of the Amsterdam University Medical Center, location AMC (number W12_011 # 12.17.0020).
: Not applicable.
: The authors declare that they have no competing interests. LV received consultancy fees from Bayer, MSD, Genentech, Servier and Pierre Fabre but these had no relation with the content of this publication.